This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
CL Bowden , JR Calabrese , G Sachs , LN Yatham , SA Asghar , M Hompland , P Montgomery , N Earl , TM Smoot , J DeVeaugh-Geiss , Lamictal 606 Study Group (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60, 392–400.
E Brown , SL McElroy , PE Keck Jr., A Deldar , DH Adams , M Tohen , DJ Williamson (2006). A seven-week comparison of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. Journal of Clinical Psychiatry 67, 1025–1033.
JR Calabrese , CL Bowden , G Sachs , LN Yatham , K Behnke , OP Mehtonen , P Montgomery , J Ascher , W Paska , N Earl , J DeVeaugh-Geiss , Lamictal 605 Study Group (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64, 1013–1024.
JR Calabrese , CL Bowden , GS Sachs , JA Ascher , E Monaghan , GD Rudd (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Journal of Clinical Psychiatry 60, 79–88.
JR Calabrese , RF Huffman , RL White , S Edwards , TR Thompson , JA Ascher , ET Monaghan , RA Leadbetter (2008). Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo controlled clinical trials. Bipolar Disorders 10, 323–333.
JR Calabrese , JR Sullivan , CL Bowden , T Suppes , JF Goldberg , GS Sachs , MD Shelton , FK Goodwin , MA Frye , V Kusumakar (2002). Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. Journal of Clinical Psychiatry 63, 1012–1019.
SA Corya , SW Andersen , HC Detke , LS Kelly , LE Van Campen , TM Sanger , DJ Williamson , S Dubé (2003). Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. Journal of Clinical Psychiatry 64, 1349–1356.
AM Crawford , CM Beasley Jr., GD Tollefson (1997). The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophrenia Research 26, 41–54.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 285, 2486–2497.
MA Frye , TA Ketter , TA Kimbrell , RT Dunn , AM Speer , EA Osuch , DA Luckenbaugh , G Cora-Ocatelli , GS Leverich , RM Post (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology 20, 607–614.
LL Judd , HS Akiskal , PJ Schettler , J Endicott , AC Leon , DA Solomon , W Coryell , JD Maser , MB Keller (2005). Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry 62, 1322–1330.
PE Keck Jr., SA Corya , LL Altshuler , TA Ketter , SL McElroy , M Case , SD Briggs , M Tohen (2005). Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. Journal of Clinical Psychiatry 66, 611–616.
PE Keck Jr., EB Nelson , SL McElroy (2003). Advances in the pharmacologic treatment of bipolar depression. Biological Psychiatry 53, 671–679.
SA Montgomery , M Asberg (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.
RM Post , KD Denicoff , GS Leverich , LL Altshuler , MA Frye , TM Suppes , AJ Rush , PE Keck Jr., SL McElroy , DA Luckenbaugh , (2003). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry 64, 680–690.
T Suppes , EB Dennehy , RM Hirschfeld , LL Altshuler , CL Bowden , JR Calabrese , ML Crismon , TA Ketter , GS Sachs , AC Swann , Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder (2005). The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. Journal of Clinical Psychiatry 66, 870–886.
M Tohen , E Vieta , J Calabrese , TA Ketter , G Sachs , C Bowden , PB Mitchell , F Centorrino , R Risser , RW Baker , (2003). Efficacy of olanzapine and olanzapine/fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 60, 1079–1088.
LN Yatham , SH Kennedy , C O'Donovan , S Parikh , G MacQueen , R McIntyre , V Sharma , P Silverstone , M Alda , P Baruch , , Canadian Network for Mood and Anxiety Treatments (2005). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 7 (Suppl. 3), 5–69.
RC Young , JT Biggs , VE Ziegler , DA Meyer (1978). A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry 133, 429–435.